Bronchial Biopsy Devices Market Size, Share and Growth Outlook, 2026

Bronchial Biopsy Devices Market Snapshot: Market Size, CAGR, and Growth Outlook (2021 to 2034)

The global Bronchial Biopsy Devices Market size is forecast to increase from $736.99 Million in 2026 to $1324.22 Million in 2034 at a CAGR of 7.6% between 2026 and 2034.

The Bronchial Biopsy Devices market report provides detailed analysis and outlook of Bronchial Biopsy Devices segments including By Product (Bronchial Biopsy Forceps, Biopsy Needles, Cryobiopsy Probes, Cytology Brushes, Procedure Trays and Kits), By Guidance Technique (Ultrasound-Guided, Fluoroscopy-Guided, Electromagnetic Navigation Bronchoscopy, CT-Guided ), By Usage (Reusable Devices, Disposable ), By Application (Lung and Bronchus Cancer Diagnosis, Chronic Obstructive Pulmonary Disease, Infectious Respiratory Diseases, Inflammatory and Interstitial Lung Diseases), By End-User (Hospitals and Specialized Respiratory Centers, Diagnostic Imaging and Pathology Laboratories, Ambulatory Surgical Centers) across global and regional markets. Further, analysis and outlook across 21 countries in North America, Europe, Asia Pacific, Middle East, Africa, and South America are provided in the study.

Bronchial Biopsy Devices Industry Overview

Expansion of Bronchoscopy Applications Across Pediatric Care

The bronchial biopsy devices industry is experiencing continued growth through expanding clinical applications and regulatory approvals that broaden patient access to advanced respiratory diagnostic procedures. Olympus Corporation of the Americas received FDA clearance for expanded pediatric indications covering two models of its single-use flexible bronchoscope portfolio. This regulatory milestone enables pulmonologists to perform bronchoscopy examinations, tissue sampling procedures, and airway inspections in younger patient populations using disposable bronchoscopic technologies. The growing adoption of single-use bronchoscopes addresses concerns related to device reprocessing, infection control, and procedural efficiency while extending advanced diagnostic capabilities to pediatric respiratory care. As healthcare providers increasingly emphasize patient safety and workflow optimization, disposable bronchoscopy platforms are becoming important tools for bronchial biopsy and pulmonary diagnostic procedures across diverse patient populations.

Advanced Ultrasound Bronchoscopes Improving Lung Cancer Diagnostics

Technological innovation remains a major driver within the bronchial biopsy devices industry, particularly in the area of endobronchial ultrasound-guided tissue sampling. Fujifilm introduced the EB-710US, a next-generation flexible ultrasound bronchoscope developed to enhance lung cancer detection and nodal staging procedures. The device incorporates a balloonless design and delivers improved image resolution along with greater depth visualization capabilities. These enhancements support more accurate endobronchial ultrasound-guided transbronchial needle aspiration (EBUS-TBNA) procedures by providing clinicians with clearer visualization of lymph nodes and surrounding anatomical structures. Improved imaging performance enables more precise guidance of fine-needle biopsy devices, supporting accurate tissue acquisition for lung cancer diagnosis, staging, and treatment planning. The growing integration of advanced ultrasound technologies into bronchoscopy systems is strengthening diagnostic confidence and improving procedural outcomes in thoracic oncology.

Next-Generation Fine Needle Biopsy Technologies Enhancing Tissue Acquisition

Manufacturers are increasingly developing specialized biopsy instruments designed to improve tissue quality and diagnostic yield from challenging pulmonary lesions. Olympus Corporation expanded its bronchial biopsy portfolio through the U.S. launch of the SecureFlex Single-Use Fine Needle Biopsy device. The system is specifically optimized for ultrasound-guided tissue sampling and incorporates a proprietary Dual-Beveled Raptor Tip engineered to penetrate complex tissue structures efficiently. The needle design enables the retrieval of larger, intact cellular architectures from tortuous and difficult-to-access lesions that may be challenging to sample using conventional biopsy instruments. High-quality tissue acquisition is becoming increasingly important as precision medicine and molecular diagnostics require larger and better-preserved specimens for comprehensive pathological and genomic analysis. The development of advanced fine needle biopsy technologies reflects the industry's focus on improving diagnostic accuracy, procedural efficiency, and tissue adequacy for personalized lung cancer management.

Bronchial Biopsy Devices Market Trends, Growth Drivers, Competitive Landscape, and Future Opportunities

The global Bronchial Biopsy Devices market is witnessing increasing investments in innovation, product development, digital transformation, artificial intelligence integration, healthcare infrastructure expansion, and strategic partnerships across developed and emerging economies. Key Companies in the industry include- Olympus Corporation, Boston Scientific Corporation, Medtronic plc, Cook Medical, Becton, Dickinson and Company (BD), Fujifilm Holdings Corporation, Teleflex Incorporated, Broncus Medical Inc., Ambu A/S, Hologic, Inc.. The Bronchial Biopsy Devices market is expected to remain one of the most closely watched segments in the global healthcare industry, with companies focusing on niche market segments. As healthcare systems across the US, Europe, Asia-Pacific, Latin America, and Middle East & Africa continue to prioritize efficiency, access, and innovation, the Bronchial Biopsy Devices industry outlook remains shaped by rising healthcare expenditure, demographic change, digital transformation, and product innovation.
The report provides detailed market analysis including-

• Growth Bronchial Biopsy Devices Market size outlook across 3 scenarios- High growth, reference, and Low growth cases

• Market Trends, Drivers, Potential Opportunities, and Challenges faced by Bronchial Biopsy Devices companies

• Porter’s Five forces analysis- Bargaining power of buyers and sellers, Threat of Substitutes and new entrants, and Intensity of competitive rivalry

• Detailed SWOT Analysis of global and regional Bronchial Biopsy Devices markets

• Competitive analysis including business description, product analysis, and financial profiles

• Key country specific analysis detailing key factors shaping the short-term and long-term outlook

• Recent industry developments and news including mergers, acquisitions, product launches, expansions, and company announcements

Bronchial Biopsy Devices Market Competitive Benchmarking and Company Analysis

Leading companies in Bronchial Biopsy Devices industry include- Olympus Corporation, Boston Scientific Corporation, Medtronic plc, Cook Medical, Becton, Dickinson and Company (BD), Fujifilm Holdings Corporation, Teleflex Incorporated, Broncus Medical Inc., Ambu A/S, Hologic, Inc.. The Bronchial Biopsy Devices market remains moderately to highly fragmented, with competition expected to intensify as companies accelerate investments in innovation, geographic expansion, strategic partnerships, and portfolio diversification through 2034. In developed markets such as the United States, Germany, France, the United Kingdom, and Canada, competition is increasingly centered on innovation, reimbursement positioning, and value-based healthcare solutions. Meanwhile, emerging markets including China, India, Brazil, and countries across the Middle East and Africa continue to present significant opportunities for expansion due to rising healthcare expenditure, growing patient populations, and increasing access to healthcare services.

What to expect in US Bronchial Biopsy Devices Markets in 2026 and beyond- Market Size, Share, Growth Rate, and Forecast to 2034

The US healthcare expenditure is forecast to reach $8.2 Trillion in 2034 from $5.5 Trillion in 2026 based on the National Health Expenditure Accounts (NHEA) data. With an aging population, rising chronic disease burden, and increasing migration toward minimally invasive and outpatient care, the Bronchial Biopsy Devices market remains one of the strongest-performing segments in the country.
The US Bronchial Biopsy Devices Companies are opting new business models, optimized pricing models, industry partnerships, and AI-enabled back end transformations to enhance efficiency and cost management. The US Bronchial Biopsy Devices market faces successive waves of challenging trends, with strong opportunities across select segments. The CMS plan to implement Medicaid from 2027 is driving states to build eligibility verification systems throughout 2026. Looking ahead to 2034, we anticipate stronger results underpinned by opportunities exist across Bronchial Biopsy Devices industry. On the medical device front, over 7,000 device manufacturers continue to gain from increasing demand from demand for implantable devices, surgical instruments, monitoring equipment, and diagnostic systems.

Canada- Proximity to the US and healthcare similarities to EU5 countries fuel sales of Canadian Bronchial Biopsy Devices markets

Canada's strong Bronchial Biopsy Devices sales performance is underpinned by an aging population and a well-developed healthcare infrastructure. Steady growth in new brand spending in rural and urban locations fuel the long-term prospects of small and medium-sized enterprises across medical, diagnostic, and therapeutic devices. The Canadian Bronchial Biopsy Devices market presents significant opportunities for U.S. exporters of medical devices, with the U.S. being Canada’s largest trading partner for this sector. Potential advantages including specialized materials, advanced manufacturing techniques, and digital technologies support the launch of new products in the country.

Germany Bronchial Biopsy Devices Trends and Perspectives to 2034- Financial sustainability, hospital restructuring, demographic pressures, and digitization of care delivery continue to shape the German healthcare industry.

Germany continues to remain the largest Bronchial Biopsy Devices market in Europe, driven by over €600 Billion healthcare expenditure, €12 Billion medical device R&D expenditure, statutory health insurance system covering 90% German population, nationwide rollout of the electronic patient record (ePA), and large-volume of Bronchial Biopsy Devices population. In particular, Research and development in Germany fuels the commercialization of cutting-edge technologies. Companies across the Germany Bronchial Biopsy Devices industry value chain are focusing on both domestic markets and exports. The country is also driving digital adoption with the Hospital Future Act driving hospitals to upgrade their information systems by 2027. Over the forecast period, aging population, rising healthcare costs, and increasing procedural volumes drive the Bronchial Biopsy Devices market outlook.

France Market Size, Growth Rate, and Forecast Analysis to 2034- Universal healthcare system, high public healthcare expenditure, and strong government support Bronchial Biopsy Devices sales through 2034

France Bronchial Biopsy Devices companies are emphasizing on opportunities for rapid, at-scale innovation to boost profitability over the long-term. The country’s National Health Insurance spending target (ONDAM) estimates 3.7% growth in the country’s healthcare expenditure. Over the forecast period, expenditure control measures, chronic disease management initiatives, workforce reforms, and efforts to improve system efficiency drive the long-term prospects.
The biggest 2026 policy frame is the PLFSS 2026. The law sets the Maladie branch spending target at €271.4 billion for 2026 and fixes the ONDAM at €117.5 billion for city care, €112.8 billion for health establishments, and €18.3 billion for elderly-care establishments and services. France’s market is also being pulled by demographics. INSEE estimates that on 1 January 2026 France had 69.1 million inhabitants, with 22% aged 65 or over. INSEE also reported that 2025 births were 645,000 and deaths were 651,000, producing a negative natural balance of about 6,000 for the first time since the end of the Second World War.

UK Bronchial Biopsy Devices Market Size, Share, and Growth Projections to 2034- Rapid growth driven by new and existing brands across the industry value chain

Small high-need consumer segments remain key priority of Bronchial Biopsy Devices distributors in the UK industry. Continuous launch of new products coupled with high expenditures support the market outlook. The UK Government financing remains the dominant funding source at 81.3% of total healthcare expenditure, or £280 billion in 2025. According to the ONS, total healthcare spending grew 7.7% nominally and 3.9% in real terms from 2024 to 2025. Similarly, out-of-pocket spending was £49 billion (14.1%) and voluntary health insurance was £9.5 billion (2.8%). The market is driven by rapid digital adoption with NHS England’s plan to give more than 500,000 staff access to new AI tools.

China Bronchial Biopsy Devices Market Growth Drivers, Revenue Trends, and Forecast- Medical insurance coverage is rapidly expanding over the past few years

China Bronchial Biopsy Devices market is undergoing a structural shift from hospital-centric care toward a more integrated system emphasizing primary care, outpatient services, and long-term care. Chinese local players are emerging as a strong pillar of Bronchial Biopsy Devices industry, offering opportunities for both competition and partnership. Over the forecast period, new and innovative product launches remain key elements driving market outlook. China's healthcare industry is increasingly centered on expanding healthcare capacity, improving access to advanced treatments, and reducing dependence on imported technologies.
The National Healthcare Security Administration reported that by end-2024, China’s basic medical insurance covered 1.32662 billion people and the coverage rate was 95%. Regional disparities in consumer spending trends continue to become more pronounced in the Chinese Bronchial Biopsy Devices industry. Over the forecast period, demand will keep shifting toward geriatrics, chronic disease management, rehabilitation, long-term care, and outpatient care, while pricing pressure will remain intense in drugs and consumables because reimbursement.

India Bronchial Biopsy Devices Market Landscape: Current Size and Long-Term Growth Outlook - Increased pricing pressures in US market is encouraging domestic vendors to expand across India

Indian Bronchial Biopsy Devices market is witnessing the rapid emergence of an ecosystem that brings together diverse companies across the industry value chain. Further, large-scale healthcare public and private investments and a steady growth in chronic conditions is driving sales of pharmaceuticals and medical devices. Further, non-retail channel is experiencing volume decrease and patients are migrating to the retail. Indian medical device firms are also combining precision engineering with lower labor costs to make world-class diagnostics, robotics, and critical care devices.

Brazil Bronchial Biopsy Devices market remains price-driven, with products domestically manufactured and accessibility offering potential opportunities

Healthcare expenditure in Brazil exceeds 10% of GDP, with the country among the highest healthcare spenders in Latin America. ANS reported 53.2 million medical-plan beneficiaries in December 2025, while IBGE projects a steady rise in older-age cohorts, with people aged 60+ already representing about 23% of the population. The price sensitive market access is broad through the public system, private coverage adds a sizeable premium layer, and reimbursement, procurement, and hospital efficiency remain key buying drivers.

Middle East and Africa Bronchial Biopsy Devices Industry Trends and Perspectives to 2034

According to the World Bank, the Middle East and North Africa population exceeds 500 million, while Sub-Saharan Africa's population exceeds 1.2 billion, making the broader MEA region one of the fastest-growing healthcare demand centers globally. The GCC countries including Saudi Arabia, United Arab Emirates, Qatar, and Kuwait continue to account for a disproportionately large share of regional healthcare spending. Government-led programs such as Saudi Arabia's Vision 2030 are accelerating investments in hospital infrastructure, private-sector participation, medical technology adoption, and healthcare digitalization. On the other hand, South Africa, Egypt, Nigeria, and Kenya remain key healthcare markets due to their large populations, expanding private healthcare sectors, and growing investments in healthcare delivery systems.

Bronchial Biopsy Devices Market Segmentation

By Product
Bronchial Biopsy Forceps
Biopsy Needles
Cryobiopsy Probes
Cytology Brushes
Procedure Trays and Kits
By Guidance Technique
Ultrasound-Guided
Fluoroscopy-Guided
Electromagnetic Navigation Bronchoscopy
CT-Guided
By Usage
Reusable Devices
Disposable
By Application
Lung and Bronchus Cancer Diagnosis
Chronic Obstructive Pulmonary Disease
Infectious Respiratory Diseases
Inflammatory and Interstitial Lung Diseases
By End-User
Hospitals and Specialized Respiratory Centers
Diagnostic Imaging and Pathology Laboratories
Ambulatory Surgical Centers

Top Companies in Bronchial Biopsy Devices Industry

Olympus Corporation
Boston Scientific Corporation
Medtronic plc
Cook Medical
Becton, Dickinson and Company (BD)
Fujifilm Holdings Corporation
Teleflex Incorporated
Broncus Medical Inc.
Ambu A/S
Hologic, Inc.

Countries Included

• North America- US, Canada, Mexico

• Europe- Germany, France, UK, Spain, Italy, Nordics, Others

• Asia Pacific- China, India, Japan, South Korea, Australia, Southeast Asia, Others

• Latin America- Brazil, Argentina, Others

• Middle East and Africa- Saudi Arabia, UAE, Other Middle East, South Africa, Other Africa

Latest Market Updates In Healthcare

Support this report with fresh, same-industry updates that strengthen topical depth and internal linking.

Market Update

Low MOQ, High-Mix Production Models for Indie & DTC Brands

The rising geopolitical and tariff-related uncertainties, in particular, amidst United States’ renewed protectionist trade stance continues to driv...

June 2025